ANGELA RICHARDSON: Open Payments
NPI 1750962510 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 64 payments from 17 companies in 2025. Trend: 2023 $549 · 2024 $846 · 2025 $1,040
Food & beverage: $1,040
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $309 |
| AstraZeneca Pharmaceuticals LP | 11 | $305 |
| Novo Nordisk Inc | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Dexcom, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: BREZTRI, VRAYLAR, UBRELVY, FARXIGA, JARDIANCE, QULIPTA, AIRSUPRA, CAPLYTA.
Industry payments across MO — which companies pay providers there.
